ERBB2 and breast carcinoma: HER2 is normally expressed on all breast epithelial cells, but HER2 gene (ERBB2) amplification and/or HER2 protein overexpression is detected in approximately 15%–20% of breast cancers and associated with more aggressive disease progression, metastasis, and a poorer prognosis [1–4].